Clinical Trial Update: Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors [Phase 3]

View source ↗

Summary

Phase 3 trial of omega-3 fatty acids for improving depression and reducing cardiovascular risk factors has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Major Depressive Disorder
• Myocardial Infarction
• Unstable Angina

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Cardiovascular Diseases, Depression | Phase 3 | Status: COMPLETED | Results posted: 2012-09-12